Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Shield Thera Share News (STX)
STX Share
Price
STX Share
News
STX Share
Chat
STX Share
Trades54
STX
Live RNS
STX Share
Charts
STX Level 2
Console
STX Live
Share Price
STX Broker
Ratings
STX Directors
Deals
STX Financial
Diary
STX
Fundamentals
STX Short
Positions
STX
Media
STX Company
Research
STX Company
Timeline
Share Price Information for Shield Thera (STX)
Last checked at -
Last checked at 
Intraday Shield Thera Share Chart
UK earnings, trading statements calendar - next 7 days
| Friday 2 September | |
| Ashmore Group PLC | Full Year Results |
| Monday 5 September | |
| Belvoir Group PLC | Half Year Results |
| Dechra Pharmaceuticals PLC | Full Year Results |
| Tuesday 6 September | |
| Accrol Group Holdings PLC | Full Year Results |
| Alumasc Group PLC | Full Year Results |
| Ashtead Group PLC | Q1 Results |
| Capricorn Energy PLC | Half Year Results |
| Gamma Communications PLC | Half Year Results |
| Headlam Group PLC | Half Year Results |
| Inspired PLC | Half Year Results |
| IQE PLC | Half Year Results |
| Lords Group Trading PLC | Half Year Results |
| Luceco PLC | Half Year Results |
| Michelmersh Brick Holdings PLC | Half Year Results |
| Midwich Group PLC | Half Year Results |
| NCC Group PLC | Full Year Results |
| PCI-PAL PLC | Full Year Results |
| Pebble Group PLC | Half Year Results |
| Quixant PLC | Half Year Results |
| STV Group PLC | Half Year Results |
| WAG Payment Solutions PLC | Half Year Results |
| WANdisco PLC | Half Year Results |
| Wednesday 7 September | |
| Bakkavor Group PLC | Half Year Results |
| Barratt Developments PLC | Full Year Results |
| Equals Group PLC | Half Year Results |
| M Winkworth PLC | Half Year Results |
| Malin Corp PLC | Half Year Results |
| Petropavlovsk PLC | Half Year Results |
| Somero Enterprises Inc | Half Year Results |
| Tissue Regenix Group PLC | Half Year Results |
| WH Smith PLC | Trading Statement |
| Thursday 8 September | |
| Arecor Therapeutics PLC | Half Year Results |
| Cairn Homes PLC | Half Year Results |
| Curtis Banks Group PLC | Half Year Results |
| Darktrace PLC | Full Year Results |
| Destiny Pharma PLC | Half Year Results |
| Duke Royalty Ltd | Full Year Results |
| Emis Group PLC | Half Year Results |
| Energean PLC | Half Year Results |
| Funding Circle Holdings PLC | Half Year Results |
| Genus PLC | Full Year Results |
| International Public Partnerships Ltd | Half Year Results |
| Melrose Industries PLC | Half Year Results |
| Mpac Group PLC | Half Year Results |
| Oakley Capital Investments Ltd | Half Year Results |
| Open Orphan PLC | Half Year Results |
| Restaurant Group PLC | Half Year Results |
| Safestore Holdings PLC | Q3 Results |
| Severfield PLC | Full Year Results |
| Shield Therapeutics PLC | Half Year Results |
| SourceBio International PLC | Half Year Results |
| Spire Healthcare Group PLC | Half Year Results |
| Sylvania Platinum Ltd | Full Year Results |
| Vistry Group PLC | Half Year Results |
| Copyright 2022 Alliance News Limited. All Rights Reserved. | |
Latest STX News
- EARNINGS AND TRADING: ProService Building Services lowers outlook
1 May 2026 - LONDON MARKET MIDDAY: FTSE falls as US-Iran talks stall
1 May 2026 - Shield Therapeutics reports positive Q1 earnings
1 May 2026 - WINNERS & LOSERS: Shield Therapeutics down on Medicaid concerns
1 May 2026 - TRADING UPDATES: Zenith Energy picks up two solar projects in Italy
27 Apr 2026 - Shield Therapeutics expects "strong" Accrufer growth as revenue rises
9 Apr 2026 - Shield's Accrufer MA application accepted in China
3 Mar 2026 - IN BRIEF: Shield Therapeutics gets three more years of US exclusivity
9 Feb 2026
Related News
IN BRIEF: Energean notes pre-emption challenge to Chevron Angola deal
Energean PLC - London-based energy company - Updates on its proposed acquisition from Chevron Corp of a 31% operated interest in Block 14 and a 15.5% ...
IN BRIEF: Funding Circle renews GBP200 million deal with Deutsche Bank
Funding Circle Holdings PLC - London-based lending platform focused on small and medium enterprises - Renews its GBP200 million forward flow agreement...
WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.
Shield Thera News
EARNINGS AND TRADING: ProService Building Services lowers outlook
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...
LONDON MARKET MIDDAY: FTSE falls as US-Iran talks stall
(Alliance News) - Stock prices in London were lower at midday on Friday, as hopes of diplomatic progress in the Middle East, and a batch of domestic d...
Shield Therapeutics reports positive Q1 earnings
(Sharecast News) - Shield Therapeutics reported first-quarter net revenue of $18m and positive EBIT on Friday, helped by a China milestone payment and...
WINNERS & LOSERS: Shield Therapeutics down on Medicaid concerns
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.
TRADING UPDATES: Zenith Energy picks up two solar projects in Italy
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Shield Therapeutics expects "strong" Accrufer growth as revenue rises
(Alliance News) - Shield Therapeutics PLC on Thursday highlighted a record performance from Accrufer, which it said helped drive a strong rise in annu...
Shield's Accrufer MA application accepted in China
(Sharecast News) - Shield Therapeutics said the Chinese National Medical Products Administration has accepted a marketing authorisation application fo...
IN BRIEF: Shield Therapeutics gets three more years of US exclusivity
Shield Therapeutics PLC - Newcastle, England-based commercial-stage pharmaceutical company - Says the US Food & Drug Administration grants an addition...
Follow the stocks
